KOVID-19 INFEKCIJA IZ ASPEKTA GASTROENTEROLOGA

Marija Branković; Igor Jovanović; Tijana Radonjić; Olivera Marković; Milica Brajković; Višeslav Popadić; Slobodan Klašnja; Marija Zdravković

doi:10.5937/smclk2-34920

Marija Branković University Hospital Medical Center Bezanijska kosa, Department of Internal medicine
Igor Jovanović KBC Bežanijska Kosa
Tijana Radonjić KBC Bežanijska Kosa
Olivera Marković KBC Bežanijska Kosa
Milica Brajković KBC Bežanijska Kosa
Višeslav Popadić KBC Bežanijska Kosa
Slobodan Klašnja KBC Bežanijska Kosa
Marija Zdravković KBC Bežanijska Kosa

DOI: https://doi.org/10.5937/smclk2-34920

Ključne reči: SARS-CoV-2, gastrointestinalni trakt, jetra, inflamatorne bolesti creva, endoskopija

Sažetak

Gastrointestinalni trakt i jetra nisu pošteđeni kada je u pitanju bolest izazvana koronavirusom 2019 (KOVID-19), jer ona ne utiče samo na respiratorni trakt, već je takođe sistemska bolest koja prouzrokuje oštećenje više organa. U ovom preglednom radu, ujedinili smo sve podatke klinički značajne za lekare koji leče pacijente
obolele od ove infekcije, posebno za gastroenterologe. Treba imati na umu da gastrointestinalni simptomi mogu biti prvi i/ili jedini pokazatelji KOVID-19 infekcije, stoga treba posumnjati na ovu infekciju kada pacijent, koji je bio izložen riziku, prijavi simptome poput proliva, gubitka apetita, bola u trbuhu, mučnine i/ili povraćanja. Gornja gastrointestinalna endoskopija tokom pandemije KOVID-19 infekcije predstavlja veliki problem, jer je reč o infekciji koja se tokom ove procedure vrlo lako prenosi kapljičnim putem, stoga je treba sprovoditi samo u hitnim slučajevima. Što se tiče pacijenata koji boluju od inflamatornih bolesti creva, oni
su često na imunosupresivnoj terapiji, ali preporuke su da im ne treba korigovati terapiju jer nisu u grupi pacijenata sa povećanim rizikom od oboljevanja od KOVID-19 infekcije. Takođe, lezija jetre prouzrokovana ovom infekcijom je rezultat mehanizama više faktora i zasigurno predstavlja razlog za brigu, pogotovo ako su
u pitanju pacijenti sa već postojećim, hroničnim bolestima jetre, te na njih treba posebno obratiti pažnju.

Reference

1. Villapol S. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. Transl Res. 2020;226:57–69.
2. Hongzhou Lu, Stratton CW, Tang Y-W. Outbreak of pneumonia of unknown etiology in Wuhan , China : The mystery and the miracle. J Med Virol. 2020;92(4):401–2.
3. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus : implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–74.
4. Yeo C, Kaushal S, Yeo D. Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol Hepatol. 2020;5(4):335–7.
5. Galanopoulos M, Gkeros F, Doukatas A, Karianakis G, Pontas C, Tsoukalas N, et al. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract. World J Gastroenterol. 2020;26(31):4579–4588.
6. Schmulson M, Dávalos MF, Berumen J. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19 (Spanish). Rev Gastroenterol Mex. 2020;85(3):282–287.
7. Chai X, Hu L, Zhang Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv. 2020;
8. Zhang H, Kang Z, Gong H, Xu D, Wang J, Li Z, et al. Digestive system is a potential route of COVID-19: an analysis of single- cell coexpression pattern of key proteins in viral entry process. Gut. 2020;69:1010–8.
9. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831–3.
10. Baj J, Karakuła-Juchnowicz H, Teresiński G, Buszewicz G, Ciesielka M, Sitarz E, et al. COVID-19 : Specific and Non-Specific Clinical Manifestations and Symptoms : The Current State of Knowledge. J Clin Med. 2020;9(6):1753.
11. Hajifathalian K, Mahadev S, Schwartz RE, Shah S, Sampath K, Schnoll-sussman F, et al. SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant. World J Gastroenterol. 2020;26(14):1546–53.
12. Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong X, et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020;5(5):434–5.
13. Neurath MF. Covid-19 and immunomodulation in IBD. Gut. 2020;69(7):1335–42.
14. Hunt RH, East JE, Lanas A, Malfertheiner P, Satsangi J, Scarpignato C, et al. COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist. Dig Dis. 2021;39(2):119–39.
15. Massironi S, Viganò C, Dioscoridi L, Filippi E, Pagliarulo M, Manfredi G, et al. Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy. Clin Gastroenterol Hepatol. 2020;18(10):2375–2377.
16. Popadic V, Klasnja S, Milic N, et al. Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy. Oxid Med Cell Longev. 2021;2021:6648199.
17. Monteleone G, Ardizzone S. Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection? J Crohns Colitis. 2020;1–3.
18. Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020;40(5):998–1004.
19. Garrido I, Liberal R, Macedo G. Review article: COVID-19 and liver disease—what we know on 1st May 2020. Aliment Pharmacol Ther. 2020;52(2):267–75.
20. Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M. COVID-19 and the liver. J Hepatol. 2020;73(5):1231–40.
21. Banales JM, Huebert RC, Karlsen T, et al. Cholangiocyte pathobiology. Nat Rev Gastroenterol Hepatol. 2019;16:269–281.
22. Bertolini A, van de Peppel IP, Bodewes FAJA, et al. Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis. Hepatology. 2020;72(5):1864–72.
23. Li J, Fan JG. Characteristics and mechanism of liver injury in 2019 coronavirus disease. J Clin Transl Hepatol. 2020;8:13–7.
24. Bangash MN, Patel J, Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. 2020;5:529–30.
25. Sun J, Aghemo A, Forner A, Valenti L. COVID-19 and liver disease. Liver Int. 2020;40:1278–81.
26. Hajifathalian K, Krisko T, Mehta A, et al. Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications. Gastroenterology. 2020;S0016-5085(20):30602–8.
27. Mohammed A, Paranji N, Chen P-H, Niu B. COVID-19 in Chronic Liver Disease and Liver Transplantation: A Clinical Review. J Clin Gastroenterol. 2021;55(3):187–94.
28. Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L, et al. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol. 2020;73(4):807–16.